Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NeuroSthlm011 AB
AB
Active
Org 5591698450
Dartanjangs Gata 68
Medical specialists activities · NACE 8622
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 218K
-3% vs 2024
EBITDA margin
66.9%
+1% vs 2024
Equity ratio
72.7%
Financial strength
Net profit 2025
SEK 115K
+1% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 218K
-3%
EBITDA
SEK 146K
+1%
Net profit
SEK 115K
+1%
Total assets
SEK 195K
-11%
Equity
SEK 142K
+1%
Employees
1
—
Company information
Legal name
NeuroSthlm011 AB
Org number
5591698450
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 september 2018
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva uthyrning, bemanning och konsultationer inom vård- och hälsosektorn och därmed förenlig verksamhet.
Contact
Address
Dartanjangs Gata 68
Email
anajovanovic@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
335
269
270
226
218
Staff expenses
—
−10
−0
−4
−13
EBITDA
227
179
218
144
146
Depreciation & amort.
−0
—
—
—
—
EBIT
227
179
218
144
146
Net financials
—
−0
0
0
0
Profit before tax
227
179
219
144
146
Tax
−48
−38
−47
−31
−32
Net profit
179
141
172
113
115
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
310
236
269
219
195
Equity
215
166
197
140
142
Long-term debt
0
—
—
—
—
Short-term debt
95
70
73
79
53
Total debt
95
70
73
79
53
Financial ratios
5-year trend
EBITDA margin
66.9%
This company
15.8%
Market median
+323% vs market
2021
2025
Equity ratio
72.7%
This company
38.2%
Market median
+90% vs market
2021
2025
Return on equity
80.8%
This company
18.4%
Market median
+339% vs market
2021
2025
Net profit margin
52.6%
This company
8.1%
Market median
+549% vs market
2021
2025
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
2021
2025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AJ
Ana Jovanovic
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
ZR
Zoran Radovic
Deputy Board Member
2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NeuroSthlm011 AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ana Jovanovic
Chief Executive Officer
0 companies
Zoran Radovic
Deputy Board Member
0 companies